Lupin’s Somerset facility clears U.S. FDA Pre-Approval Inspection for Edaravone Oral Suspension Read more
Exemptions, concessional duty on essential medicines to improve drug access: Sudarshan Jain, IPA Read more
Top 20 global biopharma firms see 1.7 per cent market cap growth to $3.7 billion in 2024 amid policy challenges Read more
Budget expectations: Leaders opine for incentives in the nutra and API manufacturing sectors Read more